Talk:Butyrophenone

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Butyrophenone. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology

This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles ??? This article has not yet received a rating on the project's importance scale.

Domperidon isn't a butyrophenon derivative; hence it doesn't belong here. It could be mentioned, since its structure was developed apart butyrophenone antidopamninics, but it isn't really a butyrophenone.--84.163.78.126 16:57, 16 August 2007 (UTC)[reply]

Butyrophenone (1-Phenyl-1-butanone, without substitution) has no relevant affinities for dopamine receptors; hence, I change the first sentence of this article. Further, I change the brief description of domperidone, since it really isn't a direct butyrophenone derivative.--84.163.78.65 (talk) 23:54, 28 November 2007 (UTC)[reply]

I have cite-tagged the statement that this drug is 200 times more potent than Thorazine. The wikipedia article for Benperidol says 75-100 times stronger. Hopefully, someone can come in with a source that will clear this up.